longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SPRY

SPRY
----

LongbridgeAI

The Nasdaq Biotechnology Index closed up nearly 1.4%, closely mirroring the performance of the Dow Jones Industrial Average. Among the constituent stocks, Esperion rose 16.09%, ARS Pharmaceuticals rose 15.50%, Anavex Life Sciences rose 12.34%, Personalis rose 12.31%, Autolus Therapeutics rose 12.10%, and Aura Biosciences rose 11.09%. AC Immune fell 5.84%, LENZ Therapeutics fell 6.51%, and Cullinan Oncology LLC fell 8.82%

Wallstreetcn
Nov 25, 2025 at 09:27 PM

The Nasdaq Biotechnology Index closed up nearly 1.4%, performing close to the Dow Jones Industrial Average. Component stock Esperion rose 16.09%, ARS Pharmaceuticals rose 15.50%, Anavex Life Sciences rose 12.34%, Personalis rose 12.31%, Autolus Therapeutics rose 12.10%, and Aura Biosciences rose 11.09%. AC Immune, on the other hand, fell 5.84%, ranking third from the bottom, LENZ Therapeutics fell 6.51%, and Cullinan Oncology LLC fell 8.82%

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

Personalis

Personalis

USPSNL

-0.98%

ARS Pharmaceuticals

ARS Pharmaceuticals

USSPRY

+5.84%

Aura Biosciences

Aura Biosciences

USAURA

-1.24%